Investment analysts at StockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a report released on Sunday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Price Performance Shares of GLMD opened at $0.39 on Friday. The stock has a market capitalization of $1.96 million, a […]